Canada Markets open in 8 hrs 52 mins

IVERIC bio, Inc. (ISEE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.26-0.18 (-1.72%)
At close: 04:00PM EDT
10.26 0.00 (0.00%)
After hours: 04:51PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.45
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 319.34
52 Week Low 35.96
50-Day Moving Average 311.80
200-Day Moving Average 314.77

Share Statistics

Avg Vol (3 month) 32.05M
Avg Vol (10 day) 32.87M
Shares Outstanding 5114.64M
Implied Shares Outstanding 6N/A
Float 881.23M
% Held by Insiders 10.58%
% Held by Institutions 1109.26%
Shares Short (Apr 28, 2022) 47.49M
Short Ratio (Apr 28, 2022) 44.61
Short % of Float (Apr 28, 2022) 46.49%
Short % of Shares Outstanding (Apr 28, 2022) 46.46%
Shares Short (prior month Mar 30, 2022) 47.23M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-23.67%
Return on Equity (ttm)-41.49%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -114.72M
Net Income Avi to Common (ttm)-114.52M
Diluted EPS (ttm)-1.11
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)381.75M
Total Cash Per Share (mrq)3.3
Total Debt (mrq)1.57M
Total Debt/Equity (mrq)0.44
Current Ratio (mrq)13.73
Book Value Per Share (mrq)2.17

Cash Flow Statement

Operating Cash Flow (ttm)-98.56M
Levered Free Cash Flow (ttm)-57.8M